OOIR: Observatory of International Research

Papers

(The TQCC of JAMA Cardiology is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Anticipating Pharmacological Perturbation With Human Genetic Variation—Lessons From CETP	332
A Woman With Recurrent Torsade de Pointes	284
A Patient in His 50s With Chest Tightness and Left Arm and Neck Tingling	228
The Case for Inclusion of a Lipid Panel in the Standard Precatheterization Laboratory Blood Draw—Stating What Should Be Obvious	224
Identifying Barriers to Initiation of Sodium-Glucose Cotransporter-2 Inhibitor Therapy in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction—Reply	223
Error in Table 1	199
Educational Attainment and Cardiovascular Risk—A Missed Opportunity?	182
JAMA Cardiology	158
Mendelian Randomization and Cardiovascular Disease—Enabling Expert Readership	148
Ventricular Septal Rupture After ST-Segment Elevation Myocardial Infarction	146
Implementing Shared Decision-making for Patients With Aortic Stenosis With Longer Life Expectancy	137
USPSTF Report on Aspirin for Primary Prevention	126
Association of Longer Leukocyte Telomere Length With Cardiac Size, Function, and Heart Failure	119
Mechanisms Underlying Alterations in Cardiac Conduction After Transcatheter Aortic Valve Replacement	118
Ticagrelor vs Prasugrel in Patients With Diabetes and Multivessel Coronary Artery Disease	116
Culturally Adapted Lifestyle Intervention for South Asian Adults With Cardiovascular Risk Factors	114
Myocardial Fibroblast Activation in Ischemic and Nonischemic Cardiomyopathy	111
Novel Controlled Metabolic Accelerator for Obesity-Related HFpEF	109
Long-Term Changes in Ventricular Function in Recreational Marathon Runners	106
JAMA Cardiology	105
Mining the Electronic Medical Record for Hypertension Treatment—Hope or Hype?	104
Blood Pressure Measurements From Self-Service Health Kiosks in US Retail Stores, 2017-2024	103
Lesion-Level Effects of LDL-C–Lowering Therapy in Patients With Acute Myocardial Infarction	100
JAMA Cardiology Peer Reviewers in 2025	99
Chest Pain in a Middle-Aged Man	97

Genome-Wide Association Study of Accessory Atrioventricular Pathways	96
Primary Prevention Management of Elevated Lipoprotein(a)	95
Quantifying and Interpreting the Prediction Accuracy of Models for the Time of a Cardiovascular Event—Moving Beyond C Statistic	93
Accountable Care Organization Participation and Cardiovascular Care Quality	93
Spontaneous Coronary Artery Dissection in a Healthy Man With Non–ST Elevation Myocardial Infarction	91
JAMA Cardiology	90
High-Intensity Interval Training vs Moderate-Intensity Continuous Training for Women Undergoing Cardiovascular Rehabilitation	90
Supraventricular Tachycardia Following Mitral Valve Surgery	88
Influenza Vaccine in High-Risk Cardiovascular Diseases—Define the Target—Reply	82
What Is Your Secret to Health?	82
JAMA Cardiology	82
Interpreting Health Status Measures in Patients With Heart Failure—What Counts	81
Peak Oxygen Uptake vs Ventilatory Efficiency	80
Race, Racism, and Risk—Implications of Social Determinants of Health in Cardiovascular Disease Prediction	77
Beware the Possible Dangers of Chemsex—Is Illicit Drug–Related Sudden Cardiac Death Underestimated?	77
Effect of Personalized Accelerated Pacing on Quality of Life, Physical Activity, and Atrial Fibrillation in Patients With Preclinical and Overt Heart Failure With Preserved Ejection Fraction	76
Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone	76
User Trust in Artificial Intelligence–Guided Lung Ultrasound	76
Contribution of Clinical Trial Event Data by Data Source	75
Critical Appraisal of the Negative Predictive Performance of the European Society of Cardiology 0/1-Hour Algorithm for Evaluating Patients With Chest Pain in the US	75
Aspirin and Hemocompatibility After LVAD Implantation in Patients With Atherosclerotic Vascular Disease	73
Left Atrial Appendage Closure After Thrombus Aspiration—Reply	73
Circulating Trimethylamine N-Oxide and Growth Rate of Abdominal Aortic Aneurysms and Surgical Risk	71
Innovation in Event Adjudication—Human vs Machine	71
Burden of Rare Genetic Variants in Spontaneous Coronary Artery Dissection With High-risk Features	67
Artificial Intelligence–Guided Lung Ultrasound by Nonexperts	66
Corrected to Open Access Status	65
Time to Treat the Climate and Nature Crisis as One Indivisible Global Health Emergency	64
Achieving Equitable Access to Acute Myocardial Infarction Therapies for Rural Patients—Is It Possible?	63
JAMA Cardiology	63
Young Man With Coarctation of the Aorta	63
PCSK9 in Familial Hypercholesterolemia and Beyond	62
Time to Clinical Benefit of Dapagliflozin in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction	62
Geographical and Urban-Rural Disparities in Cardiac Rehabilitation Eligibility and Center-Based Use in the US	61
Spectrum of Primary Aldosteronism and Risk of Cardiovascular Outcomes	61
JAMA Cardiology	61
Optimizing Cascade Testing to Advance Health Equity in Cardiac Amyloidosis	60
Epicardial and Pericardial Fat—Separated But Under the Same Roof—Reply	60
Professional Preferences and Perceptions of Cardiology Among Internal Medicine Residents	59
Circumferential Pulmonary Vein Isolation With vs Without Additional Low-Voltage-Area Ablation in Older Patients With Paroxysmal Atrial Fibrillation	59
Error in Figure	57
Potassium Nitrate in Heart Failure With Preserved Ejection Fraction	57
Error in Nonauthor Collaborator’s Name	57
Clinical Decisions and Outcomes After Switching High-Sensitivity Cardiac Troponin Assays in Suspected ACS	57
Supine Blood Pressure and Risk of Cardiovascular Disease and Mortality	57
Atrial Fibrillation and Clonal Hematopoiesis in TET2 and ASXL1	56
Mortality Among Patients With Early-Onset Atrial Fibrillation and Rare Variants in Cardiomyopathy and Arrhythmia Genes	55
Atherosclerotic Coronary Plaque Regression and Risk of Adverse Cardiovascular Events	55
Rare and Common Genetic Variation Underlying Atrial Fibrillation Risk	54
High-Intensity Interval Training vs Moderate-Intensity Continuous Training for Women Undergoing Cardiovascular Rehabilitation	54

Passing the Stethoscope	53
Error in Abstract and Results	53
A Woman With Syncope and Frequent Premature Ventricular Contractions	53
The Urgent Need to Improve Outcomes for Pregnant Cardiovascular Trainees	53
Importance of Prolonged QRS Duration in Detecting Complete Conduction Block	53
Exertional Dyspnea in a Female Patient Aged 55 Years Without Significant Medical History	53
The Politics of HFpEF—What’s Good for the Left Is Good for the Right	53
Error in Figure 1	52
Troponins and Pregnancy—Reply	52
Recognition of the Large Ambulatory C2D Stage of Advanced Heart Failure—A Call to Action	51
A New His-Ventricular Threshold for Myotonic Dystrophy Type 1—Reply	49
Athletes With Cardiovascular Disease and Competitive Sports Eligibility	49
Assessment for Long-Term Cardiovascular Disease Risk in Pregnancy	49
State-Level Cardiovascular Mortality Rates Among Hispanic, Non-Hispanic Black, and Non-Hispanic White Populations, 1990 to 2019	48
Current Landscape and Future Directions of Coronary Revascularization in Patients With Heart Failure	48
Exercise and Resistant Hypertension—Is Exercise Enough?—Reply	48
The 3.5-Inch View—On Perspective and the Medical Profession	48
When Is a Placebo Not a Placebo	47
Age Dependency of Cardiovascular Outcomes With the Amyloidogenic pV142I Transthyretin Variant Among Black Individuals in the US	47
Prioritizing the Exposome to Reduce Cardiovascular Disease Burden	47
Clonal Hematopoiesis—Fuel to Inflame the Heart	46
Cardiac Fibrosis—An Emerging Diagnostic and Therapeutic Target	46
Vigorous Exercise in Patients With Hypertrophic Cardiomyopathy	45
High-Sensitivity Troponin T and I Among Pregnant Women in the US—The National Health and Nutrition Examination Survey, 1999-2004	45
Percutaneous Intramyocardial Septal Radiofrequency Ablation in Patients With Drug-Refractory Hypertrophic Obstructive Cardiomyopathy	45
Moderate-Intensity Statin With Ezetimibe Combination Therapy vs High-Intensity Statin Monotherapy in Patients at Very High Risk of Atherosclerotic Cardiovascular Disease	45
US Trends in Prescribing Nonstatin Lipid-Lowering Therapy, 2019-2024	45
Prevalence of Statin Use for Primary Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and 10-Year Disease Risk in the US	43
Statin Eligibility for Primary Prevention of Cardiovascular Disease According to 2021 European Prevention Guidelines Compared With Other International Guidelines	43
Preserving and Promoting Clinical Trial Representativeness	43
Aggressive Risk Factor Reduction Study for Atrial Fibrillation Implications for Ablation Outcomes	43
Early Mortality in Type A Acute Aortic Dissection	43
Concomitant Mechanical Aspiration and Appendage Closure for Recalcitrant Left Atrial Appendage Thrombi	43
Patient-Level Pooled Analysis of Ultrasound Renal Denervation in the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO, and RADIANCE-HTN TRIO Trials	42
Cardiovascular Significance and Genetics of Epicardial and Pericardial Adiposity	42
JAMA Cardiology	41
Is CABG Indicated in Patients With Ischemic Cardiomyopathy?	41
Incidental Complication From a Left Atrial Appendage Device	41
The Smart(est) Choice for Dual Antiplatelet Therapy Is a Patient-Directed One	41
An Elderly Woman With Ventricular Tachycardia	40
A 65-Year-Old Woman With Dyspnea and Recurrent Abdominal Distension	40
My Grandfather’s Blueprint	39
Errors in Author Affiliations and Open Access Updated	39
JAMA Cardiology	39
Corrected to Open Access Status	38
Error in Table	38
Reflections of an Editorial Fellow—A Window Into Medical Publishing	38
Error in Abstract	38
In Honor of the Pig	37
The Limitations and Risks Associated With Semaglutide Treatment—Reply	37
Kidney Outcomes Among Medicare Beneficiaries After Hospitalization for Heart Failure	37
Preventing Declines in Cardiovascular Health From Childhood	37
Indication Creep in Transcatheter Aortic Valve Implantation—Data or Desire?	37
Error in Abstract and Text	36
PREVENT Risk Age Equations and Population Distribution in US Adults	36
Effectiveness of a Text-Based Gamification Intervention to Improve Physical Activity Among Postpartum Individuals With Hypertensive Disorders of Pregnancy	36
One-Year Outcomes of Coronary Angiography After Out-of-Hospital Cardiac Arrest Without ST Elevation	36
Tenecteplase vs Alteplase in Mechanical Prosthetic Heart Valve Thrombosis	35
Predicting the Risk of Myocardial Infarction vs the Risk of Stroke in Hypertension—Reply	34
Effects of Pitavastatin on Coronary Artery Disease and Inflammatory Biomarkers in HIV	33
Improving Behavioral Counseling for Primary Cardiovascular Disease Prevention	33
Error in Results	33
Cardiovascular Health Among Rural and Urban US Adults—Healthcare, Lifestyle, and Social Factors	33
Finerenone in Heart Failure—Reply	33
Abelacimab vs Rivaroxaban in Older Individuals With Atrial Fibrillation	33
The Last Mile in Prevention—Can Coronary CT Angiography Help?	33
Association Between High-Density Lipoprotein Cholesterol Levels and Adverse Cardiovascular Outcomes in High-risk Populations	32
JAMA Cardiology	32
Association of the Timing and Extent of Cardiac Implantable Electronic Device Infections With Mortality	32
Effects of Sacubitril/Valsartan on All-Cause Hospitalizations in Heart Failure	32
Age-Adjusted Survival Extrapolations—Results May Differ From Those Generated by the Weibull Model—Reply	31
A Young Woman With Dyspnea During Cardiac Catheterization	31
Medical Editors vs Nuclear Weapons—Is the Pen Mightier Than the Sword?	31
Medicine, Writing, and the Limits of Language	31
JAMA Cardiology	31
Moving Beyond Conventional Guesstimation to Guide PCI	31
What Role for New York Heart Association Class in Heart Failure Clinical Trials?	31
Complete vs Culprit-Only Revascularization in Older Patients With Myocardial Infarction and High Bleeding Risk	30
Trends in Transcatheter vs Surgical Mitral Valve Repair Among Medicare Beneficiaries, 2012 to 2019	30
Alternative Certification Methods for Cardiac Proceduralists	30

Fontan Junctional Rhythm—Innocent Bystander or Silent Killer?	30
Early Adoption of Sodium-Glucose Cotransporter-2 Inhibitor in Patients Hospitalized With Heart Failure With Mildly Reduced or Preserved Ejection Fraction	30
Osteosarcopenia and Mortality in Older Adults Undergoing Transcatheter Aortic Valve Replacement	30
Comment on Aspirin Avoidance in Patients With LVADs	30
Rationale, Design, and Baseline Clinical Characteristics of the Ziltivekimab Cardiovascular Outcomes Trial	29
Antibiotic Prophylaxis and Infective Endocarditis Incidence Following Invasive Dental Procedures	29
Effect of Dapagliflozin on Total Heart Failure Events in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction	29
Machine Learning–Based Models Incorporating Social Determinants of Health vs Traditional Models for Predicting In-Hospital Mortality in Patients With Heart Failure	29
JAMA Cardiology	29
High-Sensitivity vs Conventional Troponin Cutoffs for Risk Stratification in Patients With Acute Pulmonary Embolism	29
Microaxial Flow Pump Hemodynamic and Metabolic Effects in Infarct-Related Cardiogenic Shock	29
A Man in His 20s With Gradually Enlarging Mediastinal Mass and Intermittent Hemoptysis	28
More Attention Should Be Paid to Less Severe Nonculprit Lesions—Reply	28
How Do We Credit the Evidence Generated From Subgroup Analyses in Randomized Clinical Trials?—Reply	28
Man in His Sixth Decade of Life With Totally Occluded Abdominal Aorta (Leriche Syndrome)	28
The Fine Art and Science of Translating Trials Results Into Clinical Practice	27
Is There a Need for Palliative Care for Patients With Heart Failure With Preserved Ejection Fraction?	27
Health and Economic Evaluation of Sacubitril-Valsartan for Heart Failure Management	27
JAMA Cardiology	27
Exertional Syncope in a Female Teenage Student	26
Distinct Genetic Risk Profile in Aortic Stenosis Compared With Coronary Artery Disease	26
Myocardial Dysfunction in Primary Mitral Regurgitation	26
Nudging to Improve Cardiovascular Care—Clinicians, Patients, or Both	26
Trends in 10-Year Outcomes Among Medicare Beneficiaries Who Survived an Acute Myocardial Infarction	26
Coronary Angiography After Out-of-Hospital Cardiac Arrest Without ST-Segment Elevation	25
Quality of Care and Clinical Outcomes for Patients With Heart Failure at Hospitals Caring for a High Proportion of Black Adults	25
Polygenic Susceptibility in Peripartum, Alcohol-Induced, and Cancer Therapy–Related Cardiomyopathies	25
Dapagliflozin and Kidney Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction	25
Everything Right, Everything Wrong	25
Emergency Medical Service Agency Practices and Cardiac Arrest Survival	25
Plasma Proteomics of Exercise Blood Pressure and Incident Hypertension	25
Multifaceted Intensive Blood Pressure Control Model in Older and Younger Individuals With Hypertension	24
Patient Enrollment for Cardiovascular Clinical Trials in the United States	24
Inquiry Regarding Body Temperature Data in HuMAIN-HFpEF Trial	23
Influenza Vaccine in High-Risk Cardiovascular Diseases—Define the Target	23
Error in Abstract and Methods	23
AI-Assisted Point-of-Care Ultrasound Networks—Considerations for Rural Health Care Delivery	23
Beware the Possible Dangers of Chemsex—Is Illicit Drug–Related Sudden Cardiac Death Underestimated?—Reply	23
Heart Failure and Nonoptimal Temperatures	23
Chest Tube–Induced Right Ventricular Failure After Cardiac Surgery	23
Emergency Department–Based Education and mHealth Empowerment Intervention for Hypertension	23
Transient Monocular Blindness in a Man in His 30s	23
High-Risk Areas—The Trees in the Forest—Reply	23
Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Male and Female Patients	23
Adverse Pregnancy Outcomes and N-Terminal Pro-Brain Natriuretic Peptide Levels 2 to 7 Years After Delivery	23
Genetic Testing in Early-Onset Atrial Fibrillation	22
Lipoprotein(a) and Long-Term Plaque Progression, Low-Density Plaque, and Pericoronary Inflammation	22
Time to Revisit Using 10-Year Risk to Guide Statin Therapy	22
Carotid Artery Stenosis—An Impactful Bias in Ischemic Stroke Classification	22
Long-term Survival After Out-of-Hospital Cardiac Arrest	22
From the Heart: Eugene Braunwald (1929-2026)	22
Hospitalization Rates Alone Do Not Define Health Systems—Reply	22
Salt Substitution and Recurrent Stroke and Death—Reply	22
Discontinuation of Semaglutide Among Older Adults With Diabetes in the US and Japan	22
JAMA Cardiology	22
Blood Pressure Control After SPRINT—Back to Reality	21
Private Equity and Cardiovascular Health Care	21
Statin Eligibility According to Atherosclerotic Cardiovascular Disease Risk in the US	21
Variants at the Interleukin 1 Gene Locus and Pericarditis	21
Performance of the European Society of Cardiology 0/1-Hour Algorithm With High-Sensitivity Cardiac Troponin T Among Patients With Known Coronary Artery Disease	21
Hard Lessons From a School-Based Intervention to Improve Cardiovascular Health in Adolescence	21
Periconceptional Glucagon-Like Peptide-1 Receptor Agonist Use and Discontinuation	21
Comprehensive Cardiovascular Magnetic Resonance Tissue Characterization and Cardiotoxicity in Women With Breast Cancer	21
The Cost-Effectiveness Evolution of Cardiovascular Care	20
Reducing the Risks of Nuclear War—The Role of Health Professionals	20
Recommendations for Deferred Testing in Low-Risk Chest Pain—Decades Old But Now Finally Tested	20
Physiology-Guided Complete Revascularization in Older Patients With Myocardial Infarction	20
Women’s Representation in Interventional Cardiology	20
Heart Failure—Together We Go Farther—Reply	20
JAMA Cardiology Peer Reviewers in 2021	20
Long-Term Durability of Acoramidis Efficacy in Transthyretin Amyloid Cardiomyopathy	20
Educational Attainment and Lifetime Risk of Cardiovascular Disease	20
Prevalence and Overlap of Cardiac, Renal, and Metabolic Conditions in US Adults, 1999-2020	20
Management of Postpartum Left Main Spontaneous Coronary Artery Dissection	19
Can Noncalcified Plaques Contribute to Future Coronary Events?	19
Errors in Abstract	19
Exercise-Induced Dyspnea in an Older Woman With a History of Coronary Artery Disease	19
What’s VAT All About—The Clue Is in the Genetics	19
Error in Figure 1	19
Implantable Cardioverter-Defibrillators in Chagas Cardiomyopathy—Reply	18
Pathway to Risk Stratification in Tricuspid Regurgitation	18
Prevalence, Determinants, and Time Trends of Cardiovascular Health in the WHO African Region	18
Evidence Generation for Novel Cardiovascular Devices—Putting the Horse Back in Front of the Cart	18
Error in Figure	18
Prioritizing Time from Diagnosis to Quadruple Therapy in Heart Failure Care	17
Oral Semaglutide and Change in Cardiovascular Risk Factors in High-Risk Type 2 Diabetes	17
Aortic Valve Replacement for Asymptomatic Severe Aortic Stenosis—The Time Has Come	17
Social Vulnerability and Poor Health Outcomes	17
Characteristics, Process Metrics, and Outcomes Among Patients With ST-Elevation Myocardial Infarction in Rural vs Urban Areas in the US	17
High-Dose vs Standard-Dose Influenza Vaccine and Cardiovascular Outcomes in Older Adults	17
Pitavastatin, Procollagen Pathways, and Plaque Stabilization in Patients With HIV	17
Risk Prediction for Atherosclerotic Cardiovascular Disease With and Without Race Stratification	17
Electrocardiographic Findings in Female Professional Basketball Athletes	17
Hypertensive Disorders of Pregnancy and Long-Term Risk of Dilated Cardiomyopathy	16
Filling the Evidence Gaps Toward a Coronary Artery Calcium-Guided Primary Prevention Strategy	16